glp-1 supply manufacturing news today Drugmakers and CDMOs seize opportunity, invest in facilities Disruptive Innovations Shaping the GLP-1

Methods We conducted a systematic review and meta-analysis of randomised, placebo-controlled cardiovascular outcome trials evaluating GLP-1RAs in adults at high cardiovascular risk

(PubMed) Mock DM, Quirk JG, Mock NI

Overview of its approval and use in medical treatments The FDA approved semaglutide in 2017 to assist with Type 2 diabetes, including those on basal insulin

While these findings remain encouraging, much of the published evidence has been generated through laboratory and animal models, and additional research is needed to further define its biological effects

This means that bariatric surgery is often considered the better option for cost-effectiveness